Granulocyte ‐colony stimulating factor administration among hemoglobin S trait donors: A single center experience from the Eastern Mediterranean region
ConclusionG‐CSF seems safe in hemoglobin S trait donors. Their being eligible as donors would increase the chance of the patients for allogeneic stem cell transplantation in high prevalence regions. Further studies are required to reveal the safety profile of G‐SCF in hemoglobin S carriers in different regions.
Source: Journal of Clinical Apheresis - Category: Hematology Authors: Cigdem Gereklioglu, Suheyl Asma, Asl ı Korur, Songul Tepebası, Pelin Aytan, Mahmut Yeral, Ilknur Kozanoglu, Can Boga, Hakan Ozdogu Tags: RESEARCH ARTICLE Source Type: research
More News: Hematology | Sickle Cell Anemia | Statistics | Stem Cell Therapy | Stem Cells | Study | Transplants